GleamWall
中文EN

EDVA Endovia Health Sciences, Inc.

Beverages · NYSE · SEC CIK 1553788 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY79.3%
TTM net income YoY33.3%
TTM EPS YoY89.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-13.6%
Operating margin3,741.9%
Net margin4,787.7%
FCF margin—
EBITDA margin3,756.9%

Returns

ROE—
ROA-148.3%
ROIC (approx.)—
Asset turnover-0.03x

Leverage & solvency

Liabilities / assets1,563.2%
Debt / equity—
Current ratio0.05x
Interest coverage-5.67x

Cash quality & payout

Operating cash flow / net income0.31x
Accruals ratio-101.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q2*2026-06-302026Q12026-03-312025Q4*2025-12-312025Q3*2025-09-302025Q2*2025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$0$4,224-$365,206$0-$23,406$68,606-$2.77M$981,859
Cost of revenue———$0$0$468,715$929,502$690,839
Gross profit$0$1,848$47,341$0-$32,146$25,544-$343,614$291,019
SG&A expense———————$55,000
Operating income-$2.01M-$978,970-$976,411-$9.54M-$1.50M-$1.66M-$6.44M-$2.67M
Interest expense$231,020$889,455$940,855$320,013$625,047$637,345$1.66M$890,471
Income tax$0$0$0$0$0$0$0$0
Net income-$2.05M-$2.14M-$3.21M-$9.89M-$8.49M-$3.65M-$9.04M-$4.72M
EBITDA-$2.00M-$976,649-$1.08M-$9.51M-$1.46M-$1.66M-$6.44M-$2.63M
EPS (basic)—-0.47———-1.97——
EPS (diluted)—-0.47———-1.97——
Weighted avg. shares (diluted)3.06M4.57M—2.19M474,9691.86M—1.31M
Banking
Net interest income$57,156-$889,455-$940,855-$320,013-$625,047-$637,345-$1.66M-$889,734
Balance sheet
Cash & equivalents$242,702$381,195$281,435$265,667$17,213—$15,346$456,887
Receivables$14,316$20,333$15,748$139,504$140,626$172,819$191,991$595,305
Inventory$54,922$54,922$33,538$855,326$855,326$861,053$319,104$1.34M
Current assets$900,407$708,848$631,993$1.97M$1.61M$1.69M$1.90M$3.04M
PP&E, net—$10,605$12,926$93,756$130,773$167,791$22,210$241,766
Goodwill———————$256,823
Intangibles———————$4.17M
Total assets$1.08M$769,953$965,694$22.49M$22.24M$2.51M$2.76M$8.36M
Current liabilities$16.83M$16.97M$16.26M$15.64M$13.45M$20.42M$19.37M$17.78M
Long-term debt—$857$3,418$58,130$52,534$2.08M$1.97M$1.32M
Total debt—$857$3,418$58,130$52,534$2.08M$1.97M$1.32M
Total liabilities$16.83M$16.97M$16.27M$15.71M$13.52M$22.54M$21.39M$19.19M
Shareholders' equity-$15.75M-$16.20M-$15.30M$6.78M$8.72M-$20.03M-$18.63M-$10.83M
Net debt—-$380,338-$278,017-$207,537$35,321—$1.96M$865,983
Shares outstanding749,4503.00M749,4501.67M1.67M1.90M1.67M44.33M
Cash flow statement
Operating cash flow-$1.09M-$930,492-$991,221-$2.42M-$551,123-$808,046-$1.62M-$2.65M
Capital expenditure——————$0—
Free cash flow——————-$1.62M—
Investing cash flow——————$0-$4,735
Financing cash flow$1.16M$1.05M$977,842$2.67M$696,356$755,810$1.16M$3.01M
Depreciation & amortization$8,284$2,321-$101,769$37,017$37,017$2,321-$3,720$37,017
Stock-based compensation$1.11M$176,972$677,328$7.75M$53,859$135,709$271,013$186,682

Free plan shows the latest 8 periods; Pro shows all 58 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.